Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xuefan Yu
Institutions:
Tongji University,
Harbin Medical University,
Third Affiliated Hospital of Harbin Medical University
Observed institutions:
Tongji University,
Harbin Medical University,
Third Affiliated Hospital of Harbin Medical University,
Heilongjiang Academy of Medical Sciences
ORCID:
0009-0006-0873-246X
Observed ORCIDs:
0009-0006-0873-246X,
0009-0001-3513-109X
OpenAlex ID:
A5011644485
Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD‐mediated pyroptosis in colorectal cancer
2024
·
Xin Guan
, Ruiqi Liu
, et al.
·
Clinical and Translational Medicine
·
53
A “One Arrow Three Eagle” Strategy to Improve CM‐272 Primed Bladder Cancer Immunotherapy
2023
·
Ruiqi Liu
, Jiani Yang
, et al.
·
Advanced Materials
·
38
Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2024
·
Luying Cui
, Ruiqi Liu
, et al.
·
Cancer Research
·
36
Employing Piezoelectric Mg 2+ ‐Doped Hydroxyapatite to Target Death Receptor‐Mediated Necroptosis: A Strategy for Amplifying Immune Activation
2024
·
Jiani Yang
, Yaqian Du
, et al.
·
Advanced Science
·
32
PDF
EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail
2023
·
Jiani Yang
, Yuanyu Liao
, et al.
·
Cancer Letters
·
23
Inhibition of KAT6A enhances immunotherapy efficacy in colorectal cancer by activating interferon response
2025
·
Shuling Han
, Zhuo Chen
, et al.
·
Cancer Letters
·
10
China special issue on gastrointestinal tumors‐Regulatory‐immunoscore—A novel indicator to guide precision adjuvant chemotherapy in colorectal cancer
2023
·
Lin Fang
, Yang Yao
, et al.
·
International Journal of Cancer
·
9
Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer
2024
·
Yuanyu Liao
, Rui Yang
, et al.
·
Oncogene
·
8
Comparative efficacy and toxicity of immune checkpoint inhibitors in combination with or without chemotherapy treatment for advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis
2022
·
Yue Ma
, Yu Xin
, et al.
·
Frontiers in Oncology
·
2
Supplementary Table 2 from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2025
·
Luying Cui
, Ruiqi Liu
, et al.
Materials and Methods from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2025
·
Luying Cui
, Ruiqi Liu
, et al.
Figure S1-12 from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2025
·
Luying Cui
, Ruiqi Liu
, et al.
Raw metabolomics data from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2025
·
Luying Cui
, Ruiqi Liu
, et al.
Supplementary WB raw data from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2025
·
Luying Cui
, Ruiqi Liu
, et al.
Supplementary table 1 from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2025
·
Luying Cui
, Ruiqi Liu
, et al.
Data from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2025
·
Luying Cui
, Ruiqi Liu
, et al.
Research on Three-Port Converter Based on Switching Multiplexing and Its Power Path Optimization
2025
·
Xuefan Yu
, Ting Qian
, et al.
·
Lecture notes in electrical engineering
Show more works
View as search
Works count:
17
Citation count:
211
H-index:
8
I10-index:
6
Year
Topic
Type
